Your browser doesn't support javascript.
loading
Immunogenomic Landscape of Hematological Malignancies.
Dufva, Olli; Pölönen, Petri; Brück, Oscar; Keränen, Mikko A I; Klievink, Jay; Mehtonen, Juha; Huuhtanen, Jani; Kumar, Ashwini; Malani, Disha; Siitonen, Sanna; Kankainen, Matti; Ghimire, Bishwa; Lahtela, Jenni; Mattila, Pirkko; Vähä-Koskela, Markus; Wennerberg, Krister; Granberg, Kirsi; Leivonen, Suvi-Katri; Meriranta, Leo; Heckman, Caroline; Leppä, Sirpa; Nykter, Matti; Lohi, Olli; Heinäniemi, Merja; Mustjoki, Satu.
Afiliação
  • Dufva O; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision
  • Pölönen P; Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Brück O; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision
  • Keränen MAI; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland.
  • Klievink J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland.
  • Mehtonen J; Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Huuhtanen J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland.
  • Kumar A; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Malani D; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Siitonen S; Department of Clinical Chemistry, UH and HUSLAB, HUH, 00029 Helsinki, Finland.
  • Kankainen M; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision
  • Ghimire B; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Lahtela J; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Mattila P; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Vähä-Koskela M; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Wennerberg K; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Granberg K; Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University (TU), 33014 Tampere, Finland.
  • Leivonen SK; Department of Oncology, HUH CCC, 00029 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland.
  • Meriranta L; Department of Oncology, HUH CCC, 00029 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland.
  • Heckman C; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
  • Leppä S; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Department of Oncology, HUH CCC, 00029 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland.
  • Nykter M; Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University (TU), 33014 Tampere, Finland.
  • Lohi O; Tampere Center for Child Health Research, TU and Tays Cancer Center, Tampere University Hospital, 33521 Tampere, Finland.
  • Heinäniemi M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland. Electronic address: merja.heinaniemi@uef.fi.
  • Mustjoki S; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision
Cancer Cell ; 38(3): 380-399.e13, 2020 09 14.
Article em En | MEDLINE | ID: mdl-32649887
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide / Regulação Neoplásica da Expressão Gênica / Linfoma Difuso de Grandes Células B / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide / Regulação Neoplásica da Expressão Gênica / Linfoma Difuso de Grandes Células B / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article